2Tsuda E, Kamiya T,Ono Y, et al. Incidence of stenotic lesions predicted by acute phase changes in coronary [ J ]. Pediatr Cardiol,2005,26: 73 - 79.
3Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome [ J ]. N Engl J Med,1991, 324:1633 - 1639.
4Durongpisikul K, Soongswang J, Laohaprasitiporn D, et al. Immunoglobulin failure and retreatent in Kawasaki disease[J ]. Pediatr Cardiol, 2003,24:145 - 148.
5Fong NC, Hui YW, Li CK, et al. Evaluation of the efficacy of treatment of Kawasaki disease before day 5 of illness [J ]. Pediatr Cardiol, 2004, 25: 31-34.
6Kato H, Koike S, Yokoyama T. Kawasaki disease: effect of treatment of treatment on coronary involvement [J]. Pediatrics, 1979,62:175 - 179.
7Kusakawa S. Long- term administrative care of Kawasaki disease[J]. Acta PediatrJap, 1983,25:205- 209.
3Takeuchi M, Matsushita T, Kurotobi S, et al. Application of signal-averaged electrocardiogram to myocardial damage in the late stage of Kawasaki disease[J]. Circ J, 2006,70 (11) : 1443- 1445.
4Perez-Rodon J, Aboal J, Morales M, et al. Kawasaki disease with coronary artery lesions in adults[J].Rev Esp Cardiol, 2006,59 (11) : 1203-1204.
5Sittiwangkul R,Pongprot Y, Silvilairat S, et al. Management and outcome of intravenous gammaglobulin-resistant Kawasaki disease[J]. Singapore Med J, 2006,47 (9) : 780-784.
